Shares of General Motors were down slightly after Ford said its first-quarter profit would be lower than expected. » Read More
By: John Harwood
As they scramble for "yes" votes on their health-care plan, House leaders have a nightmare scenario in mind. » Read More
By: George Manessis
Using hedge fund analytics tool Kensho, CNBC ran a screen to see which financial companies tended to rebound after a drop like this week's. » Read More
By: Evelyn Cheng
Investor sentiment jumped to a 16-year high in Q1, according to the Wells Fargo/Gallup Investor and Retirement Optimism Index. » Read More
Best Buy continues its post-earnings surge, and one trader believes the stock could keep rallying.
For the entire month of August, the 10-year bond yield has pretty much been stuck between 1.50 and 1.59 percent.
Dunkin' Brands CEO Nigel Travis tells CNBC he's using new products and technology to get more young people in the door.
Bank of America Merrill Lynch reaffirmed its buy rating on Lowe's and added the retailer to its US1 top ideas list.
Shares of Express sink after the company reported weaker-than-expected quarterly sales and earnings.
After Pfizer's $14 billion proposed acquisition of Medivation, these biotech stocks could emerge as winners, if history is any guide.
Some of the names on the move ahead of the open.
Priscilla Hancock of JPMorgan Asset Management explains when she believes the Federal Reserve will hike interest rates.
The Japanese yen has been a star performer in 2016, and everyone is wondering where this currency goes next.
The "Fast Money" traders share their first moves for the market open.
Jim Cramer is seeing signs that companies are buying back stocks as a message that they are undervalued.
Jim Cramer goes off the charts to find two stocks that could explode higher in the return of retail.
The furniture maker said it saw its quarterly same-store sales decline by 1.9 percent.
UBS analysts upgraded their rating of CF Industries and increased a 12-month price target, sending the company's shares higher.
Clovis Oncology shares shot up more than 26 percent Tuesday after the FDA accepted the company's new drug application.
Both Tesla Motors and SolarCity shares gave up their gains after Tesla announced new versions of its Model S and Model X.
Toll Brothers reported a rise in revenue for the fourth straight quarter, beating analysts' estimates.
As major averages continue to scale new highs, one Wall Street firm believes the stock market rally is getting overdone.
Gold mining stocks are having a great year so far, but one technical analyst urges investors to wait and see.
Cramer said he doesn't want to bet against J.M. Smucker CEO Mark Smucker after the company posted quarterly revenue that fell short.
Get the best of CNBC in your inbox